About
Liaoning Chengda Biotechnology Co., Ltd. is an international advanced virus vaccine production technology platform introduced from the United States. It was established in Shenyang in June 2002 as a high-tech enterprise. Companies adhering to the "integrity integrity, benevolence and harmony" of the core values, is committed to research and development, production and promotion of "international level, domestic leading" biological products, the main products for Chengda speed up human rabies vaccine and Chengda Libao people type B Encephalitis inactivated vaccine. Chengda Bio was listed on the New Third Board on December 31, 2014 with a registered capital of 360 million. It is controlled by Liaoning Chengda Co., Ltd. (600739), and its profitability and appreciation potential are among the top three new board companies. The production base is located in the National High-tech Park of Weinan, Shenyang, covering an area of nearly 100 acres, with a construction area of over 5
Investment Focus
- Sectors
- biotech
- Location
- Shenyang, China
Contact Information
Find more investors like Liaoning
Search Investors